Functional roles of long non-coding RNA in human breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 5993-5997

  Ye, Ni ^a   Wang, Bin ^a   Quan, Zi Fang ^a   Cao, San Jie ^a   Wen, Xin Tian ^a   Huang, Yong ^a   Huang, Xiao Bo ^a   Wu, Rui ^a   Ma, Xiao Ping ^a   Yan, Qi Gui ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Biological function; Breast cancer; Long non Coding RNAs; Tumorigenic mechanism

Indexed keywords

LONG UNTRANSLATED RNA;

BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84906258139     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.5993     Document Type: Short Survey

References (54)

1. Balasubramanian S, Eckert RL (2007). Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol, 224, 214-9.
2. Barsyte-Lovejoy D, Lau SK, Boutros PC, et al (2006). The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res, 66, 5330-7.
3. Berteaux N, Lottin S, Monté D, et al (2005). H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem, 280, 29625-36.
4. Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 9, 582-9.
5. Cesana M, Cacchiarelli D, Legnini I, et al (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell, 147, 358-69.
6. Chen L-L, Carmichael GG (2009). Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: Functional role of a nuclear noncoding RNA. Mol Cell, 35, 467-78.
7. Chen L-L, Carmichael GG (2010). Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol, 22, 357-64.
8. Chen W, Böcker W, Brosius J, et al (1997). Expression of neural BC200 RNA in human tumours. J Pathol, 183, 345-51.
9. Clemson CM, Hutchinson JN, Sara SA, et al (2009). An Architectural Role for a Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of Paraspeckles. Mol cell, 33, 717-26.
10. Clemson CM, McNeil JA, Willard HF, et al (1996). XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J Cell Biol, 132, 259-75.
11. Coccia EM, Cicala C, Charlesworth A, et al (1992). Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation and development. Mol Cell Biol, 12, 3514-21.
12. Fejes-Toth K, Sotirova V, Sachidanandam R, et al (2009). Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature, 457, 1028-32.
13. Fellig Y, Ariel I, Ohana P, et al (2005). H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol, 58, 1064-8.
14. Flynn RA, Chang HY (2012). Active chromatin and noncoding RNAs: an intimate relationship. Curr Opin Gene Dev, 22, 172-8.
15. Fox AH, Bond CS, Lamond AI (2005). P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. Mol Biol Cell, 16, 5304-15.
16. Gabory A, Jammes H, Dandolo L (2010). The H19 locus: Role of an imprinted non-coding RNA in growth and development. Bioessays, 32, 473-80.
17. Giannoukakis N, Deal C, Paquette J, et al (1993). Parental genomic imprinting of the human IGF2 gene. Nat Genet, 4, 98-101.
18. Gupta RA, Shah N, Wang KC, et al (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-6.
19. Hassan S, Buchanan M, Jahan K, et al (2011). CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer, 129, 225-32.
20. Hibi K, Nakamura H, Hirai A, et al (1996). Loss of H19 imprinting in esophageal cancer. Cancer Res, 56, 480-2.
21. Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer P, 14, 6221-5.
22. Hung T, Wang Y, Lin MF, et al (2011). Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet, 43, 621-9.
23. Hutvágner G, Zamore PD (2002). A microRNA in a multipleturnover RNAi enzyme complex. Science, 297, 2056-60.
24. Kino T, Hurt DE, Ichijo T, et al (2010). Noncoding RNA gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Sci Signal, 3, ra8.
25. Lai EC (2002). MicroRNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet, 30, 363.2.
26. Lottin S, Adriaenssens E, Dupressoir T, et al (2002). Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis, 23, 1885-95.
27. Lv J, Yu YQ, Li SQ, et al (2014). Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. Asian Pac J Cancer Prev, 15, 2565-70.
28. Matouk IJ, DeGroot N, Mezan S, et al (2007). The H19 noncoding RNA is essential for human tumor growth. PLoS One, 2, e845.
29. Mourtada-Maarabouni M, Pickard M, Hedge V, et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208.
30. Olson P, Lu J, Zhang H, et al (2009). MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Gene Dev, 23, 2152-65.
31. Pei CH, Wu HY, Fan FT, et al (2014). Influence of curcumin on HOTAIR-mediated migration of human renal cell carcinoma cell. Asian Pac J Cancer Prev, 15, 4239-43.
32. Ponting CP, Belgard TG (2010). Transcribed dark matter: meaning or myth? Hum Mol Genet, 19, R162-8.
33. Qiao HP, Gao WH, Huo JX, et al (2013). Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev, 14, 1077-82.
34. Rinn JL, Kertesz M, Wang JK, et al (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 129, 1311-23.
35. Sasaki Y, Hiro se T, et al (2009), How to build a paraspeckle. Genome Biol, 10, 227.
36. Schneider C, King RM, Philipson L et al (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-93.
37. Silva JM, Boczek NJ, Berres MW et al(2011).LSINCT 5 is overexpressed in breast and ovarian cancer and affects cellular proliferation. Rna Bilo, 8, 496-505.
38. Smaldone MC, Davies BJ, et al (2010). BC-819 a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther, 12, 607-16.
39. Sunwoo H, Dinger ME, Wilusz JE, et al (2009). MEN ε/β nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res, 19, 347-59.
40. Swanton C, Caldas C (2009). Molecular classification of solid tumours: towards pathway-driven therapeutics. Brit J Cancer, 100, 1517-22.
41. Szymanski M, Barciszewski J (2006). RNA regulation in mammals. Ann NY Acad Sci, 1067, 461-8.
42. Tsai M-C, Manor O, Wan Y, et al (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329, 689-93.
43. Tsai M-C, Spitale RC, Chang HY (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3-7.
44. Tsang WP, Ng EK, Ng SS, et al (2010). Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 31, 350-8.
45. Wan Yue, Howar Y (2010). Flight of noncoding RNAs in cancer metastasis. Cell Cycle, 9, 3391-2.
46. Wang J, Liu X, Wu H, et al (2010). CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res, 38, 5366-83.
47. Wang KC, Chang HY (2011). Molecular mechanisms of long noncoding RNAs. Mol Cell, 43, 904-14.
48. Wapinski O, Chang HY (2011). Long noncoding RNAs and human disease. Trends Cell Biol, 21, 354-61.
49. Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Gene Dev, 23, 1494-504.
50. Yang tao, Li jun tang, Wang li juan, et al (2012). The influence of interference IncRNAs HOTAIR in human breast cancer cells MDA-MB-231. Chin J Cell Mol Immunol, 28, 97-8.
51. Yan L-X, Huang X-F, Shao Q, et al (2008). MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-60.
52. Zemel S, Bartolomei MS, Tilghman SM (1992). Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nat Genet, 2, 61-5.
53. Zeng Y, Yi R, Cullen BR (2003). MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA, 100, 9779-84.
54. Zhang Y, Tycko B (1992). Monoallelic expression of the human H19 gene. Nat Genet, 1, 40-44.